Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Mar 21, 2018
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether performing a hip arthroscopy, which is a minimally invasive surgery to look inside the hip joint, at the same time as a periacetabular osteotomy (PAO) can improve recovery and outcomes for patients with hip dysplasia. The PAO is a surgery that helps realign the hip joint to relieve pain and improve function. Participants in this study will be randomly assigned to either have only the PAO or to have both surgeries at the same time.
To be eligible for this trial, participants must be between 16 and 50 years old and have a specific type of hip problem called acetabular dysplasia. They also need to be able to understand the study and give their consent. Unfortunately, those who have had previous hip surgeries, certain medical disorders, or specific types of arthritis cannot participate. If you join the study, you will receive careful monitoring and follow-up to assess your recovery and overall outcomes after the surgeries. This research aims to provide clearer answers on the best approach to treating hip dysplasia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Skeletally mature patient undergoing Bernese periacetabular osteotomy for symptomatic acetabular dysplasia/hip instability
- • Pre-Operative MRI at 3T and/or gadolinium MR arthrogram
- • Age, 16-50 years old
- • Patient capable of giving informed consent
- Exclusion Criteria:
- • Prior hip/pelvis surgery of any kind on the surgical side
- • Prior hip arthroplasty surgery on either side
- • Radiographic evidence of arthritis (i.e. Tönnis grade =2)
- • Known connective tissue disorder (e.g. Ehlers-Danlos Syndrome, etc.)
- • Known neuromuscular disorder (e.g. Cerebral Palsy, Spina bifida, etc.)
- • Known skeletal dysplasia (e.g. Achondroplasia, Multiple Epiphyseal Dysplasia, etc.)
- • Cognitive impairment that prevents accurate completion of patient-reported outcome questionnaires.
- • Patient unable/unwilling to complete all required follow-up visits
- • Concurrent proximal femoral osteotomy and/or surgical hip dislocation
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
New York, New York, United States
Ottawa, Ontario, Canada
Royal Oak, Michigan, United States
Ottawa, Ontario, Canada
Québec, , Canada
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Geoffrey Wilkin, MD
Principal Investigator
The Ottawa Hospital Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials